ARS Pharmaceuticals Inc (SPRY) Q3 2024 Earnings Call Highlights: Strong Cash Position and NEPHI ...

By Yahoo! Finance | Nov 14, 2024 at 02:13 AM EST

Initial inventory stocking was lower than expected due to distributor caution, but it is expected to improve. Cash redemption is higher than expected, with success in prior authorizations. NEPHI is attracting patients due to ease of use, including parents of children with food allergies.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.